PricewaterhouseCoopers (PwC) released a report last month showing the healthcare industry’s perception of the Food and Drug Administration (FDA). Following what was heard and seen during the annual conference of AdvaMed last October, the report demonstrated that 78% of the life science industry executives believe that "the FDA has improved the quality and frequency of its communication in the past two years." Entitled "FDA and Industry: A recipe for collaborating in the New Health Economy," the report interviewed 100 senior executives from the healthcare industry.
The FDA improved in several ways. The great majority of the executives responded that the agency provided actionable feedbacks and offered more "applicable guidance, rules and regulations”. Another interesting point showed by the report is the direct correlation between participating in meetings with the FDA at key moments during clinical development or before submitting an application and how good the relationship is between the agency and the healthcare companies.